He Mu Biotechnology Overview
- Year Founded
-
2022

- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
7
He Mu Biotechnology General Information
Description
Developer of animal mRNA vaccines in China designed to protect the development of the animal husbandry industry. The company's vaccines provide a comprehensive solution for pathogen detection and prevention and includes more than ten animal mRNA vaccines for pigs, cattle and pets, enabling the animal husbandry industry in China to protect its livestock against viral diseases.
Contact Information
Website
www.hemubio.comCorporate Office
- Room 1503, 15/F, Tower D, Tsinghua Tongfang Technology Building
- No.1 Wangzhuang Road, Haidian District
- Beijing
- China
Corporate Office
- Room 1503, 15/F, Tower D, Tsinghua Tongfang Technology Building
- No.1 Wangzhuang Road, Haidian District
- Beijing
- China
He Mu Biotechnology Timeline
He Mu Biotechnology Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Early Stage VC | 12-Dec-2023 | Completed | Generating Revenue | |||
2. Seed Round | 14-Dec-2022 | Completed | Startup | |||
1. Seed Round | 22-Oct-2022 | Completed | Startup |
He Mu Biotechnology Investors (7)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Asia Green Fund | PE/Buyout | Minority | ||
Intelligent Fund of Funds | Venture Capital | Minority | ||
Tsinghua Capital | Venture Capital | Minority | ||
China-U.S. Green Fund | Venture Capital | Minority | ||
Tianjin Yiyi Hygiene Products | Corporation | Minority |
He Mu Biotechnology FAQs
-
When was He Mu Biotechnology founded?
He Mu Biotechnology was founded in 2022.
-
Where is He Mu Biotechnology headquartered?
He Mu Biotechnology is headquartered in Beijing, China.
-
What industry is He Mu Biotechnology in?
He Mu Biotechnology’s primary industry is Other Commercial Products.
-
Is He Mu Biotechnology a private or public company?
He Mu Biotechnology is a Private company.
-
What is He Mu Biotechnology’s current revenue?
The current revenue for He Mu Biotechnology is
. -
How much funding has He Mu Biotechnology raised over time?
He Mu Biotechnology has raised $2.19M.
-
Who are He Mu Biotechnology’s investors?
Asia Green Fund, Intelligent Fund of Funds, Tsinghua Capital, China-U.S. Green Fund, and Tianjin Yiyi Hygiene Products are 5 of 7 investors who have invested in He Mu Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »